K.L. Krishna

1.2k total citations
41 papers, 872 citations indexed

About

K.L. Krishna is a scholar working on Complementary and alternative medicine, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, K.L. Krishna has authored 41 papers receiving a total of 872 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Complementary and alternative medicine, 9 papers in Endocrinology, Diabetes and Metabolism and 8 papers in Molecular Biology. Recurrent topics in K.L. Krishna's work include Medicinal Plants and Neuroprotection (9 papers), Natural Antidiabetic Agents Studies (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). K.L. Krishna is often cited by papers focused on Medicinal Plants and Neuroprotection (9 papers), Natural Antidiabetic Agents Studies (9 papers) and Cholinesterase and Neurodegenerative Diseases (6 papers). K.L. Krishna collaborates with scholars based in India, Saudi Arabia and Malaysia. K.L. Krishna's co-authors include Jagruti A. Patel, A. Jain, Lokesh Deb, Manish Soni, Seema Mehdi, N. Vishal Gupta, M. P. Venkatesh, H.V. Gangadharappa, Shahid Ud Din Wani and Yam Nath Paudel and has published in prestigious journals such as International Journal of Pharmaceutics, Journal of Ethnopharmacology and Life Sciences.

In The Last Decade

K.L. Krishna

37 papers receiving 758 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
K.L. Krishna India 14 219 197 176 168 130 41 872
Abdel Razik H. Farrag Egypt 20 265 1.2× 114 0.6× 239 1.4× 178 1.1× 70 0.5× 69 1.0k
Rekha R. Shenoy India 17 167 0.8× 90 0.5× 233 1.3× 70 0.4× 155 1.2× 56 892
Iahtisham Ul‐Haq Pakistan 14 186 0.8× 146 0.7× 228 1.3× 231 1.4× 67 0.5× 27 1.0k
Rehab F. Abdel‐Rahman Egypt 23 234 1.1× 126 0.6× 371 2.1× 234 1.4× 197 1.5× 84 1.4k
Vadivelan Ramachandran India 13 115 0.5× 91 0.5× 199 1.1× 79 0.5× 117 0.9× 55 668
Atul Kabra India 18 200 0.9× 218 1.1× 188 1.1× 88 0.5× 104 0.8× 70 886
A. C. Rana India 12 175 0.8× 132 0.7× 129 0.7× 101 0.6× 61 0.5× 36 645
Nur Najihah Izzati Mat Rani Malaysia 21 159 0.7× 152 0.8× 356 2.0× 98 0.6× 53 0.4× 40 1.2k
Hye-Jin Kim South Korea 17 182 0.8× 100 0.5× 306 1.7× 88 0.5× 86 0.7× 55 1.0k
Woan Sean Tan Malaysia 8 327 1.5× 119 0.6× 340 1.9× 136 0.8× 108 0.8× 8 1.2k

Countries citing papers authored by K.L. Krishna

Since Specialization
Citations

This map shows the geographic impact of K.L. Krishna's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K.L. Krishna with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K.L. Krishna more than expected).

Fields of papers citing papers by K.L. Krishna

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K.L. Krishna. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K.L. Krishna. The network helps show where K.L. Krishna may publish in the future.

Co-authorship network of co-authors of K.L. Krishna

This figure shows the co-authorship network connecting the top 25 collaborators of K.L. Krishna. A scholar is included among the top collaborators of K.L. Krishna based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K.L. Krishna. K.L. Krishna is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Johnson, Asha P., K. Pramod, K.L. Krishna, et al.. (2025). Cubosome-dissolving microneedle system enhances the anti-psoriatic efficacy of a synergistic combination of methotrexate and cyclosporine. International Journal of Pharmaceutics. 681. 125893–125893. 1 indexed citations
2.
3.
Raghavendra, Vinay B., et al.. (2024). Recent advances on Nigella sativa – A promising herb: Antihypertensive properties, thimoquinone nanoformulations, and health applications. Pharmacological Research - Natural Products. 3. 100052–100052. 2 indexed citations
4.
5.
Krishna, K.L., et al.. (2023). Psoriasis and skin cancer – Is there a link?. International Immunopharmacology. 121. 110464–110464. 15 indexed citations
6.
Kameshwar, Vivek Hamse, et al.. (2023). Diosmin: A Daboia russelii venom PLA2s inhibitor- purified, and characterized from Oxalis corniculata L medicinal plant. Journal of Ethnopharmacology. 318(Pt B). 116977–116977. 5 indexed citations
7.
Parray, Zahoor Ahmad, et al.. (2023). Beyond Glucose: The Dual Assault of Oxidative and ER Stress in Diabetic Disorders. High Blood Pressure & Cardiovascular Prevention. 30(6). 513–531. 14 indexed citations
8.
Mehdi, Seema, et al.. (2023). A review on linking stress, depression, and insulin resistance via low-grade chronic inflammation. Biochemistry and Biophysics Reports. 36. 101571–101571. 43 indexed citations
9.
Mehdi, Seema, et al.. (2023). Biomarkers and signaling pathways of diabetic nephropathy and peripheral neuropathy: possible therapeutic intervention of rutin and quercetin. Diabetology International. 15(2). 145–169. 4 indexed citations
10.
Huwaimel, Bader, Ahmed Alobaida, El‐Sayed Khafagy, et al.. (2022). Manganese chloride (MnCl2) induced novel model of Parkinson’s disease in adult Zebrafish; Involvement of oxidative stress, neuroinflammation and apoptosis pathway. Biomedicine & Pharmacotherapy. 155. 113697–113697. 24 indexed citations
11.
Mehdi, Seema, et al.. (2021). Recent advances, novel targets and treatments for cholelithiasis; a narrative review. European Journal of Pharmacology. 908. 174376–174376. 30 indexed citations
12.
Krishna, K.L., et al.. (2021). Combination of Ocimum sanctum extract and Levetiracetam ameliorates cognitive dysfunction and hippocampal architecture in rat model of Alzheimer’s disease. Journal of Chemical Neuroanatomy. 120. 102069–102069. 12 indexed citations
13.
Krishna, K.L., et al.. (2020). Anti-tumor potential of cucurbitacin triterpenoids of Momordica dioica Roxb. fruit by EAC induced ascites tumor model. International Journal of Research in Pharmaceutical Sciences. 11(2). 1793–1797. 1 indexed citations
14.
Paudel, Yam Nath, et al.. (2019). Envisioning the neuroprotective effect of Metformin in experimental epilepsy: A portrait of molecular crosstalk. Life Sciences. 233. 116686–116686. 25 indexed citations
15.
Krishna, K.L., et al.. (2014). DESIGN, SYNTHESIS AND IN VITRO ANTI-CANCER ACTIVITY OF NOVEL 1,2,4-TRIAZOLE DERIVATIVES. International Journal of Pharmacy and Pharmaceutical Sciences. 6(10). 185–189. 4 indexed citations
16.
Krishna, K.L., et al.. (2014). Protective effect of tulsi and levetiracetam on memory impairment induced by pregabalin on mice. IOSR Journal of Pharmacy and Biological Sciences. 9(1). 46–52. 2 indexed citations
17.
Krishna, K.L., et al.. (2013). ANTIAMNESIC ACTIVITY OF GUGGUL EXTRACT ON SCOPOLAMINE INDUCED AMNESIA IN MICE. International Journal of Pharmacy. 3(8). 403–409. 1 indexed citations
18.
Krishna, K.L., et al.. (2011). PHARMACOLOGICAL PROFILES OF BACOPA MONNIERI: A Review. International Journal of Pharmacy. 1(1). 15–23. 20 indexed citations
19.
Jain, A., et al.. (2007). Antioxidant and hepatoprotective activity of ethanolic and aqueous extracts of Momordica dioica Roxb. leaves. Journal of Ethnopharmacology. 115(1). 61–66. 196 indexed citations
20.
Krishna, K.L., et al.. (2006). Diuretic Activity of Sufoof-e-Suzak Qawi an Unani Polyherbomineral Formulation. TSpace. 5(2). 167–169. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Abdel Razik H. Farrag Breakdown of academic impact, for papers by Rekha R. Shenoy Breakdown of academic impact, for papers by Iahtisham Ul‐Haq Breakdown of academic impact, for papers by Rehab F. Abdel‐Rahman Breakdown of academic impact, for papers by Vadivelan Ramachandran Breakdown of academic impact, for papers by Atul Kabra Breakdown of academic impact, for papers by A. C. Rana Breakdown of academic impact, for papers by Nur Najihah Izzati Mat Rani Breakdown of academic impact, for papers by Hye-Jin Kim Breakdown of academic impact, for papers by Woan Sean Tan
Rankless by CCL
2026